Correction: Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial

Bibliographic Details
Main Authors:	Bruno Dubois, Jesús López‑Arrieta, Stanley Lipschitz, Triantafyllos Doskas, Luiza Spiru, Svitlana Moroz, Olena Venger, Patrick Vermersch, Alain Moussy, Colin D. Mansfield, Olivier Hermine, Magda Tsolaki, for the AB09004 Study Group Investigators
Format:	Article
Language:	English
Published:	BMC 2023-04-01
Series:	Alzheimer’s Research & Therapy
Online Access:	https://doi.org/10.1186/s13195-023-01230-9

Internet